27-June-2023
English
15-June-2023
English
9-June-2023
English
31-May-2023
English, PDF, 682kb
From alternative protein sources to rapid vaccine development, synthetic biology can address global challenges and transform industries. But are current governance frameworks up to the task?
24-May-2023
English
10-May-2023
English
26-April-2023
English
20-April-2023
English
The OECD Pharmaceutical Pricing Policy project had two main objectives: to add to the base of information about pharmaceutical pricing policy in OECD countries and develop a taxonomy and framework for making international comparisons of policies, and to analyse cross-national impacts and implications of policies, particularly with respect to the impacts on pharmaceutical prices paid in other countries and on pharmaceutical R&D.
20-April-2023
English
Variations in per capita health spending can be the result of differences in prices for healthcare goods and services, and in the quantity of care that individuals are using (“volume”). Eurostat and the OECD have calculated purchasing power parities and price level indexes for GDP and some 50 product groups, including health and hospitals, on a regular and timely basis.